Healthequity, inc. (HQY)
CashFlow / Yearly
Jan'20Jan'19Jan'18Jan'17Jan'16Jan'15Jan'14Jan'13
Cash flows from operating activities:
Net income

39,664

73,899

47,362

26,376

16,613

10,166

1,233

11,169

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

55,352

18,185

15,952

13,186

8,601

5,890

4,270

3,365

Deferred taxes

3,665

408

4,306

-2,891

-2,178

1,593

3,552

-4,905

Stock-based compensation

39,844

21,057

14,310

8,398

5,883

2,525

57

47

(Gains) losses on marketable equity securities and other

23,151

-1,173

-597

96

23

0

0

-

Loss on revaluation of warrant liability

-

-

-

-

-

-

614

14

Loss on revaluation of redeemable convertible preferred stock derivative

-

-

-

-

-

735

5,363

103

Loss on other investments

-

-

-

-

-

-24

0

0

Bad debt expense

-

-

-

35

24

31

0

-100

Imputed interest on notes payable

-

-

-

-

-

-

38

112

Changes in operating assets and liabilities:
Restricted cash

-

-

-

-

-

-

-791

752

Accounts receivable

5,009

4,306

4,734

2,728

5,174

3,380

1,546

-571

Inventories

-

-

-

-

-5

234

118

-18

Other assets

12,577

5,893

760

1,343

107

1,608

272

25

Operating lease right-of-use assets

-6,218

-

-

-

-

-

-

-

Letter of credit cash deposit

-

-

-

-

-

-

-

-86

Accounts payable

-3,839

863

-581

567

1,011

-1,156

1,492

245

Due to trust

-

-

-

-

-

-

-791

752

Accrued compensation

4,550

4,432

3,827

946

2,475

1,167

1,334

770

Accrued liabilities and other current liabilities

5,759

3,031

484

1,729

-383

-802

1,808

213

Operating lease liabilities, non-current

-5,383

-

-

-

-

-

-

-

Income taxes payable

-

-

-

-

-

-

-77

65

Other long-term liabilities

-83

573

939

1,220

-252

95

267

22

Net cash provided by operating activities

105,010

113,422

81,702

45,591

26,541

15,046

18,015

11,770

Cash flows from investing activities:
Acquisitions, net of cash acquired

1,644,575

0

2,882

-

-

-

-

-

Purchases of marketable securities

53,845

728

483

379

40,291

0

0

-

Purchases of property and equipment

7,286

3,869

5,458

3,645

2,376

1,712

1,595

831

Purchases of software and capitalized software development costs

25,654

9,978

10,380

9,030

6,896

6,420

3,844

1,906

Acquisition of intangible member assets

9,134

1,195

17,545

0

40,489

0

0

-

Acquisition of a business

-

-

-

0

0

-

-

-

Proceeds from sale of marketable securities

0

41,422

0

0

-

-

-

-

Note receivable from shareholder

-

-

-

-

-

-

800

-800

Purchases of other investments

-

-

-

-

500

305

0

0

Net cash provided by (used in) investing activities

-1,740,494

25,652

-36,748

-13,054

-90,552

-8,437

-4,639

-3,537

Cash flows from financing activities:
Proceeds from long-term debt

1,250,000

0

0

-

-

-

-

-

Payment of debt issuance costs

30,504

0

0

-

-

-

-

-

Principal payments on long-term debt

7,813

0

0

-

-

-

-

-

Settlement of client-held funds obligation

215,790

0

0

-

-

-

-

-

Repayment of notes payable

-

-

-

-

-

-

2,167

7,568

Dividend payments

-

-

-

-

-

50,347

694

0

Proceeds from initial public offering, net of payments for offering costs

-

-

-

-

-

132,587

0

0

Repurchase of redeemable convertible preferred stock and convertible preferred stock

-

-

-

-

-

-

3,371

0

Proceeds from follow-on offering, net of payments for offering costs

458,495

0

0

-

23,492

0

0

-

Proceeds from exercise of common stock options

11,347

22,929

14,564

7,142

1,915

2,430

523

110

Proceeds from exercise of common stock warrants

-

-

-

-

-

2,380

74

0

Tax benefit from exercise of common stock options

-

-

-

16,634

11,557

3,429

271

0

Deferred financing costs paid

-

-

-

-

317

0

-

-

Net cash provided by financing activities

1,465,735

22,929

14,564

23,776

36,647

90,479

-5,364

-7,458

Increase (decrease) in cash and cash equivalents

-169,749

162,003

59,518

56,313

-27,364

97,088

8,012

775

Supplemental cash flow data:
Interest expense paid in cash

21,806

203

203

213

51

0

38

331

Income taxes paid in cash, net of refunds received

9,277

587

27

863

1,356

-1,504

353

274

Supplemental disclosures of non-cash investing and financing activities:
Equity-based acquisition consideration

3,776

0

0

-

-

-

-

-

Purchase price adjustment of acquired intangible members assets

-

-

-

-

104

0

0

-

Purchases of property and equipment included in accounts payable or accrued liabilities at period end

487

37

0

25

45

0

0

-

Conversion of preferred stock to common stock

-

-

-

-

-

50,822

0

0

Preferred stock accretion

-

-

-

-

-

4,021

-5,764

-1,258

Reclassification of series D-3 redeemable convertible preferred stock derivative liability

-

-

-

-

-

6,917

0

0

Conversion of common stock warrants to common stock

-

-

-

-

-

2,334

1,128

750

Debt issuance costs accrued during the period

-

-

-

-

-

-

0

-

Series D-3 redeemable convertible preferred stock dividend

-

-

-

-

-

-

0

609

Customer relationships
Purchases of intangible assets

0

0

1,409

0

-

-

-

-

Software
Purchases of intangible assets

1,742

200

3

330

-

193

0

-